Zhangzhou, China Zhangzhou Pientzehuang Pharmaceutical is the famous Corporate Investor, which was founded in 1999. The main office of represented Corporate Investor is situated in the Zhangzhou. The fund was located in Asia if to be more exact in China.
The typical case for the fund is to invest in rounds with 3 participants. Despite the Zhangzhou Pientzehuang Pharmaceutical, startups are often financed by Jianxin Capital. The meaningful sponsors for the fund in investment in the same round are SDIC Fund Management, CMB International Capital Corporation.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2017. The fund is generally included in less than 2 deals every year.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the various public portfolio startups of the fund, we may underline LP Pharmaceuticals Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Biopharma, Pharmaceutical.
Related Funds
| Fund Name | Location |
| BFS Capital | Coral Springs, Florida, United States |
| Corbis Images | Seattle, United States, Washington |
| IRI | Chicago, Illinois, United States |
| JDS Sports, LLC | New York, New York, United States |
| Mid-America Angels | Kansas, Overland Park, United States |
| Shanghai Wohong Investment Management | China, Shanghai |
| Sistema Asia Fund | Central Region, Singapore, Singapore |
| Triveni Engineering & Industries | India, Noida, Uttar Pradesh |
| United Microelectronics | Hsinchu, Taiwan, Taiwan Province |
| Yi Kun Venture Capital | China, Hangzhou, Zhejiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
| $30M | 20 Dec 2017 | Siming, Fujian |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
| $30M | 20 Dec 2017 | Siming, Fujian |
